Correlation Between Roivant Sciences and Ultragenyx

Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Roivant Sciences and Ultragenyx, you can compare the effects of market volatilities on Roivant Sciences and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and Ultragenyx.

Diversification Opportunities for Roivant Sciences and Ultragenyx

-0.2

Correlation Coefficient

Roivant Sciences  Ultragenyx

Good diversification

The 3 months correlation between Roivant and Ultragenyx is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and Ultragenyx go up and down completely randomly.

Pair Corralation between Roivant Sciences and Ultragenyx

Given the investment horizon of 90 days Roivant Sciences is expected to generate 0.81 times more return on investment than Ultragenyx. However, Roivant Sciences is 1.24 times less risky than Ultragenyx. It trades about 0.02 of its potential returns per unit of risk. Ultragenyx is currently generating about -0.22 per unit of risk. If you would invest  1,197  in Roivant Sciences on September 20, 2024 and sell it today you would earn a total of  18.00  from holding Roivant Sciences or generate 1.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Roivant Sciences  vs.  Ultragenyx

Roivant Sciences

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Roivant Sciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable forward indicators, Roivant Sciences is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Ultragenyx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Roivant Sciences and Ultragenyx

The main advantage of trading using opposite Roivant Sciences and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.

The idea behind Roivant Sciences and Ultragenyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.